Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

MABE: a new enkephalin analogue with analgesic potential

Aug. 11, 1998

New CNS agents described by French team

Aug. 11, 1998

4030W92 antihyperalgesic effect due to preferential action on slow activation state of Na+ channel

Aug. 11, 1998

Japanese investigators study antinociceptive dynorphin analogue

Aug. 10, 1998

Promising new antipsychotic agent in active development at Gedeon Richter

Aug. 10, 1998

Exelon demonstrates robust effects on cognitive function in Alzheimer's disease patients

Aug. 10, 1998

Clinical trials to begin shortly with KT-7515/CEP-1347

July 31, 1998

Schizophrenia collaboration between Neurogen and Schering-Plough ends successfully

July 31, 1998

Investigation at Sumitomo leads to new psychotropic agents

July 31, 1998

NMDA subtype-selective blockers prepared and evaluated at Roche

July 31, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...